EDGAR Filing Documents for 0001144204-17-003043

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001144204-17-003043

Filing Date

2017-01-20

Accepted

2017-01-20 12:34:19

Documents

Group Members

AUGUSTINE LAWLORCHRISTOPHER MIRABELLI, PH.D.HAROLD R. WERNERHEALTHCARE PARTNERS VIII, L.P.HEALTHCARE PARTNERS VIII, LLCJAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G	v457238_sc13g.htm	SC 13G	156756
	Complete submission text file	0001144204-17-003043.txt		158555

Mailing Address 44 NASSAU STREET PRINCETON NJ 08542

Business Address 44 NASSAU STREET PRINCETON NJ 08542 609-430-3913

HealthCare Ventures VIII, L.P. (Filed by) CIK: 0001358990 (see all company filings)

IRS No.: 841684310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139

Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096

PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89403 | Film No.: 17538065
SIC: 2834 Pharmaceutical Preparations